Introduction: Personalized medicine: what is it and what are the challenges?
- PMID: 29935651
- DOI: 10.1016/j.fertnstert.2018.04.027
Introduction: Personalized medicine: what is it and what are the challenges?
Abstract
Personalized medicine and precision medicine are presenting new opportunities for better patient care, but also present unique challenges. The traditional randomized clinical trial is not necessarily the most appropriate approach to evaluating what may be the best treatment for an individual. Alternative study designs pose unique regulatory challenges for the U.S. Food and Drug Administration but offer the opportunity for higher response rates. Ovarian stimulation for assisted reproductive technology offers opportunities for personalized and more precise approaches to individual patient care.
Keywords: Personalized medicine; randomized controlled trial; study design.
Copyright © 2018 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Comment in
-
Re: Introduction:J Urol. 2019 Mar;201(3):426-427. doi: 10.1097/01.JU.0000553669.64428.19. J Urol. 2019. PMID: 30759644 No abstract available.
Similar articles
-
Personalized medicine: motivation, challenges, and progress.Fertil Steril. 2018 Jun;109(6):952-963. doi: 10.1016/j.fertnstert.2018.05.006. Fertil Steril. 2018. PMID: 29935653 Free PMC article. Review.
-
Personalized ovarian stimulation for assisted reproductive technology: study design considerations to move from hype to added value for patients.Fertil Steril. 2018 Jun;109(6):968-979. doi: 10.1016/j.fertnstert.2018.04.037. Fertil Steril. 2018. PMID: 29935655 Review.
-
Group sequential designs for developing and testing biomarker-guided personalized therapies in comparative effectiveness research.Contemp Clin Trials. 2013 Nov;36(2):651-63. doi: 10.1016/j.cct.2013.08.007. Epub 2013 Aug 29. Contemp Clin Trials. 2013. PMID: 23994669 Free PMC article.
-
On study designs and hypotheses for clinical trials with predictive biomarkers.Contemp Clin Trials. 2017 Nov;62:140-145. doi: 10.1016/j.cct.2017.08.014. Epub 2017 Aug 31. Contemp Clin Trials. 2017. PMID: 28838813
-
Personalized reproductive medicine on the brink: progress, opportunities and challenges ahead.Reprod Biomed Online. 2013 Dec;27(6):611-23. doi: 10.1016/j.rbmo.2013.09.010. Reprod Biomed Online. 2013. PMID: 24449934 Review.
Cited by
-
Precision medicine and metabolic syndrome.ARYA Atheroscler. 2022 Jul;18(4):1-10. doi: 10.22122/arya.2022.26215. ARYA Atheroscler. 2022. PMID: 36817343 Free PMC article. Review.
-
Short Chain Fatty Acid Metabolism in Relation to Gut Microbiota and Genetic Variability.Nutrients. 2022 Dec 16;14(24):5361. doi: 10.3390/nu14245361. Nutrients. 2022. PMID: 36558520 Free PMC article. Review.
-
Personalizing medicine in Africa: current state, progress and challenges.Front Genet. 2023 Sep 19;14:1233338. doi: 10.3389/fgene.2023.1233338. eCollection 2023. Front Genet. 2023. PMID: 37795248 Free PMC article. Review.
-
GVBD rate is an independent predictor for pregnancy in ICSI patients with surplus immature oocytes.Front Endocrinol (Lausanne). 2023 Jan 9;13:1022044. doi: 10.3389/fendo.2022.1022044. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36699025 Free PMC article.
-
Pharmacogenetic analysis using artificial intelligence (AI) to identify polymorphisms associated with sub-optimal ovarian response and hyper-response.J Assist Reprod Genet. 2025 Jun;42(6):1863-1873. doi: 10.1007/s10815-025-03471-z. Epub 2025 Apr 2. J Assist Reprod Genet. 2025. PMID: 40172774
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical